{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:48:58Z","timestamp":1791582538465,"version":"4.3.4"},"reference-count":36,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n \n Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by impairments in social communication, restricted and repetitive behaviors, and deficits across multiple developmental domains. Although conventional interventions, including speech, behavioral, and occupational therapies, improve functional outcomes, many children continue to experience persistent cognitive and adaptive impairments. Ayurvedic formulations such as\n Saraswata Ghrita<\/jats:italic>\n and\n Ayush Manas<\/jats:italic>\n possess neuroprotective, anti-inflammatory, antioxidant, and cognition-enhancing properties, but robust clinical evidence supporting their adjunctive use in ASD is limited.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The study aims to evaluate the efficacy of a comprehensive Ayurveda intervention as an adjunct to conventional therapy in children with ASD by assessing changes in behavioral symptoms, intellectual functioning, adaptive behavior, parental quality of life, and exploratory inflammatory biomarkers.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This randomized, open-label, parallel-group, active-controlled clinical trial will enroll 80 children aged 6 to 15 years diagnosed with ASD according to\n DSM-5<\/jats:italic>\n (\n Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition<\/jats:italic>\n ) criteria at the Central Ayurveda Research Institute (CARI), Bengaluru, in collaboration with selected autism therapy centers. Participants will be randomized in a 1:1 ratio to receive either conventional therapy alone or conventional therapy combined with\n Saraswata Ghrita<\/jats:italic>\n and\n Ayush Manas<\/jats:italic>\n for 6 months. Outcome assessments will be performed at predefined intervals using the Autism Treatment Evaluation Checklist (ATEC), Indian Scale for Assessment of Autism (ISAA), Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV), Vineland Adaptive Behavior Scales, Third Edition (VABS-III), and Quality of Life in Autism (QoLA) questionnaire. Exploratory laboratory assessments include high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor-alpha (TNF-\u03b1). Safety will be evaluated through adverse event monitoring and laboratory investigations. Statistical analysis will be performed after data verification. Data normality will be assessed using the Shapiro-Wilk test. Variables will be represented as frequencies (%), mean (SD), or median with IQR. Preintervention and postintervention comparisons will use repeated-measures ANOVA or the Friedman test, as appropriate, with significance set at\n P<\/jats:italic>\n <.05, using STATA software (version 18.0; StataCorp LLC).\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Ethical approval was obtained before study initiation, and the trial was registered with the Clinical Trials Registry\u2013India (CTRI\/2025\/04\/085035). Participant recruitment commenced on December 3, 2025. As of July 17, 2026, 20 participants had been enrolled and completed baseline assessments; 14 had completed the 90-day follow-up, and 2 had completed the 6-month intervention. Recruitment is expected to continue until August 2027, followed by completion of participant follow-up, data analysis, and dissemination of study findings.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The study will provide high-quality evidence regarding the effectiveness of integrating Ayurveda with conventional therapy for children with ASD. By simultaneously evaluating behavioral, cognitive, adaptive, quality-of-life, and exploratory biological outcomes, the trial is expected to strengthen the evidence base for multidisciplinary integrative care and inform the development of standardized treatment strategies for ASD.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/99910","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:52:45Z","timestamp":1791579165000},"page":"e99910-e99910","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional Evaluation of the Efficacy of a Comprehensive Ayurveda Approach as an Add-On to Conventional Therapy in Children With Autism Spectrum Disorder: Protocol for a Randomized, Open-Label, Parallel-Group, Active-Controlled Clinical Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-3148","authenticated-orcid":false,"given":"Vidyashree","family":"Anchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-1447","authenticated-orcid":false,"given":"Thejaswini","family":"C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4133-4931","authenticated-orcid":false,"given":"Srinibash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-1224","authenticated-orcid":false,"given":"Sonam","family":"Chandhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-3225","authenticated-orcid":false,"given":"B C S","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-2006","authenticated-orcid":false,"given":"Renu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9017-8598","authenticated-orcid":false,"given":"Meghna","family":"P P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4098-8814","authenticated-orcid":false,"given":"Sindhu","family":"C V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0749-2481","authenticated-orcid":false,"given":"Rakshitha","family":"Kotian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3976-4978","authenticated-orcid":false,"given":"N","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"R1","unstructured":"ICD-11 for mortality and morbidity statistics. World Health Organization. 2025. URL: https:\/\/icd.who.int\/browse\/2025-01\/mms\/en [Accessed 12-09-2026]"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association; 2013. [doi: 10.1176\/appi.books.9780890425596]","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7402a1","article-title":"Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years - Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022","volume":"74","author":"Shaw","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"R4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/02711214050250040101","article-title":"The usage and perceived outcomes of early intervention and early childhood programs for young children with autism spectrum disorder","volume":"25","author":"Hume","journal-title":"Topics Early Child Spec Educ"},{"issue":"5","key":"R5","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56050245","article-title":"Relationship between vitamin deficiencies and co-occurring symptoms in autism spectrum disorder","volume":"56","author":"Robea","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"R6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1176\/appi.focus.24022004","article-title":"Innate immune dysfunction and neuroinflammation in autism spectrum disorder (ASD)","volume":"22","author":"Hughes","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-026-03068-6","article-title":"Inflammatory cytokine alterations in autism spectrum disorder and attention-deficit\/hyperactivity disorder: a systematic review and network meta-analysis","author":"Chen","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.101053","article-title":"Recent advances in pharmacological management of autism: a narrative review","volume":"18","author":"Abhilasha","journal-title":"Cureus"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Tripathi J.S. Deole Y.S. . Unmada nidana adhyaya. In: Khandel SK Godatwar P Deole YS Basisht G , editors. Charaka Samhita New Edition 1st Ed. Jamnagar, Ind: CSRTSDC; 2020. URL: https:\/\/www.carakasamhitaonline.com\/index.php?title=Unmada_Nidana [Accessed 08-10-2026]","DOI":"10.47468\/CSNE.2020.e01.s02.008"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115199","article-title":"Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats","volume":"293","author":"Abhishek","journal-title":"J Ethnopharmacol"},{"issue":"19","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191911852","article-title":"Effects of acute ashwagandha ingestion on cognitive function","volume":"19","author":"Xing","journal-title":"Int J Environ Res Public Health"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112876","article-title":"Ashwagandha in brain disorders: a review of recent developments","volume":"257","author":"Zahiruddin","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"R13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/0973-7847.99949","article-title":"Nootropic herbs (Medhya Rasayana) in Ayurveda: an update","volume":"6","author":"Kulkarni","journal-title":"Pharmacogn Rev"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.5455\/AAM.85160","article-title":"Potential of Saraswata Ghrita against Alzheimer\u2019s disease\u2014a review","volume":"10","author":"Badal","journal-title":"Ann Ayurvedic Med"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2025.106788","article-title":"Exploring the therapeutic potential of Bacopa monnieri in autism spectrum disorder: a comprehensive review","volume":"186","author":"Indika","journal-title":"Fitoterapia"},{"issue":"11","key":"R16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.96183","article-title":"Ashwagandha as an adaptogenic herb: a comprehensive review of immunological and neurological effects","volume":"17","author":"Jamnekar","journal-title":"Cureus"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076733","article-title":"Autism intervention meta-analysis of early childhood studies (Project AIM): updated systematic review and secondary analysis","volume":"383","author":"Sandbank","journal-title":"BMJ"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","DOI":"10.3390\/children5020025","article-title":"Autism Treatment Evaluation Checklist (ATEC) norms: a \u201cgrowth chart\u201d for ATEC score changes as a function of age","volume":"5","author":"Mahapatra","journal-title":"Children (Basel)"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-019-0138-4","article-title":"Autism spectrum disorder","volume":"6","author":"Lord","journal-title":"Nat Rev Dis Primers"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"McConachie H Parr JR Glod M et al. Systematic review of tools to measure outcomes for young children with autism spectrum disorder. In: Health Technology Assessment. NIHR Journals Library; 2015:1-506. URL: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK299302 [Accessed 12-09-2026]","DOI":"10.3310\/hta19410"},{"key":"R21","unstructured":"Autism spectrum disorder in under 19s: support and management. National Institute for Health and Care Excellence (NICE); 2021. URL: https:\/\/www.nice.org.uk\/guidance\/cg170\/resources\/autism-spectrum-disorder-in-under-19s-support-and-management-pdf-35109745515205 [Accessed 12-09-2026]"},{"issue":"1","key":"R22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3447","article-title":"Identification, evaluation, and management of children with autism spectrum disorder","volume":"145","author":"Hyman","journal-title":"Pediatrics"},{"issue":"3","key":"R23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2788.2010.01359.x","article-title":"Is the Autism Treatment Evaluation Checklist a useful tool for monitoring progress in children with autism spectrum disorders?","volume":"55","author":"Magiati","journal-title":"J Intellect Disabil Res"},{"issue":"5","key":"R24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s10803-018-3699-2","article-title":"Longitudinal epidemiological study of autism subgroups using Autism Treatment Evaluation Checklist (ATEC) score","volume":"50","author":"Mahapatra","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"R25","first-page":"269","volume":"23","author":"Memari","journal-title":"Iran J Pediatr"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Rimland B Edelson SM . Autism treatment evaluation checklist (ATEC). Autism Research Institute. 1999. URL: https:\/\/autism.org\/autism-treatment-evaluation-checklist\/ [Accessed 12-09-2026]","DOI":"10.1037\/t03995-000"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Wechsler D . Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV). Pearson Assessment; 2003. [doi: 10.1037\/t15174-000]","DOI":"10.1037\/t15174-000"},{"key":"R28","unstructured":"Sparrow SS Cicchetti DV Saulnier CA . Vineland Adaptive Behavior Scales. 3rd ed. Pearson; 2016. URL: https:\/\/www.pearsonassessments.com\/en-us\/Store\/Professional-Assessments\/Behavior\/Vineland-Adaptive-Behavior-Scales-%7C-Third-Edition\/p\/100001622?srsltid=AfmBOoprZMe1oowrYkZd2I37ZmpYgt7vbriX1j80QA1u7mKJ9oUmVXqV [Accessed 12-09-2026]"},{"key":"R29","unstructured":"Indian scale for assessment of autism (ISAA). National Institute for the Mentally Handicapped; 2009. URL: https:\/\/thenationaltrust.in\/upload\/uploadfiles\/files\/ISAA%20TEST%20MANNUAL(2).pdf [Accessed 12-09-2026]"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/160783","article-title":"Conceptualisation and development of a quality of life measure for parents of children with autism spectrum disorder","volume":"2014","author":"Eapen","journal-title":"Autism Res Treat"},{"issue":"4","key":"R31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249970","article-title":"Psychometric properties of a screening tool for autism in the community-The Indian Autism Screening Questionnaire (IASQ)","volume":"16","author":"Chakraborty","journal-title":"PLoS ONE"},{"key":"R32","volume":"25","author":"Deshmukh","journal-title":"Ann Rom Soc Cell Biol"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-52","article-title":"IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation","volume":"8","author":"Wei","journal-title":"J Neuroinflammation"},{"issue":"8","key":"R34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.9734\/jocamr\/2025\/v26i8695","article-title":"Decoding autism through Ayurveda: a holistic exploration of pathophysiology and therapeutics","volume":"26","author":"Meena","journal-title":"J Compl Altern Med Res"},{"issue":"1","key":"R35","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-022-01310-w","article-title":"The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis","volume":"48","author":"Salari","journal-title":"Ital J Pediatr"},{"issue":"2","key":"R36","doi-asserted-by":"publisher","DOI":"10.3390\/ph11020056","article-title":"Inflammation and neuro-immune dysregulations in autism spectrum disorders","volume":"11","author":"Siniscalco","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:52:47Z","timestamp":1791579167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e99910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":36,"URL":"https:\/\/doi.org\/10.2196\/99910","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"v15i2e99910"}}